Diabetes Insipidus, Neurogenic
"Diabetes Insipidus, Neurogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genetic or acquired polyuric disorder caused by a deficiency of VASOPRESSINS secreted by the NEUROHYPOPHYSIS. Clinical signs include the excretion of large volumes of dilute URINE; HYPERNATREMIA; THIRST; and polydipsia. Etiologies include HEAD TRAUMA; surgeries and diseases involving the HYPOTHALAMUS and the PITUITARY GLAND. This disorder may also be caused by mutations of genes such as ARVP encoding vasopressin and its corresponding neurophysin (NEUROPHYSINS).
MeSH Number(s)
C12.777.419.135.750
C13.351.968.419.135.750
C19.700.159.750
Concept/Terms
Diabetes Insipidus, Neurogenic- Diabetes Insipidus, Neurogenic
- Diabetes Insipidus, Neurohypophyseal
- Neurohypophyseal Diabetes Insipidus
- Diabetes Insipidus, Central
- Central Diabetes Insipidus
- Diabetes Insipidus, Pituitary
- Pituitary Diabetes Insipidus
- Neurogenic Diabetes Insipidus
Below are MeSH descriptors whose meaning is more general than "Diabetes Insipidus, Neurogenic".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Insipidus, Neurogenic".
This graph shows the total number of publications written about "Diabetes Insipidus, Neurogenic" by people in Harvard Catalyst Profiles by year, and whether "Diabetes Insipidus, Neurogenic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Diabetes Insipidus, Neurogenic" by people in Profiles.
-
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial. Lancet Diabetes Endocrinol. 2023 07; 11(7):454-464.
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia. Eur J Endocrinol. 2020 Jul; 183(1):G9-G15.
-
Lower Oxytocin Levels Are Associated with Lower Bone Mineral Density and Less Favorable Hip Geometry in Hypopituitary Men. Neuroendocrinology. 2021; 111(1-2):87-98.
-
Neuroimaging of central diabetes insipidus-when, how and findings. Neuroradiology. 2018 Oct; 60(10):995-1012.
-
A case of central diabetes insipidus after ketamine infusion during an external to internal carotid artery bypass. J Clin Anesth. 2017 Feb; 36:72-75.
-
Transient Intraoperative Central Diabetes Insipidus in Moyamoya Patients Undergoing Revascularization Surgery: A Mere Coincidence? A A Case Rep. 2016 Apr 15; 6(8):224-7.
-
Hypoparathyroidism and central diabetes insipidus: in search of the link. Eur J Pediatr. 2014 Dec; 173(12):1731-4.
-
Central diabetes insipidus: a previously unreported side effect of temozolomide. J Clin Endocrinol Metab. 2013 Oct; 98(10):3926-31.
-
Hypothalamic pituitary complications in Kabuki syndrome. Pituitary. 2013 Jun; 16(2):133-8.
-
A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient. Eur J Hum Genet. 2014 Jan; 22(1):140-3.